In reference to the TEDI Networks (Trans European Drug Information) recently published advocacy paper, this panel is oriented towards future directions facing the current unstable drug market in Europe. The event is meant to focus on different analytical techniques and promising technical developments in face of an increasingly challenging drug market (e.g. newly emerging substances and adulterants or highly potent substances such as new synthetic opioids).

Starting with a very short introduction of the key elements of TEDIs advocacy paper, the stage will be given to 5 short inputs of experts in this field (10min max.) in which challenges, special characteristics and current approaches will be demonstrated separately for the most relevant substance groups for drug checking. Following these short inputs, ample room will be provided to have in-depth discussions with a special focus on giving a voice to the audience.

co-curated by Nights

English Health / Harm Reduction